Clinical trial
A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of MK-3102 to Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy
After 24 weeks, to assess the effect of the addition of treatment with MK- 3102 compared to placebo on A1C.
To assess the safety and tolerability of MK-3102.
| Category | Value |
|---|---|
| Study start date | 2013-02-05 |